Trials / Terminated
TerminatedNCT00139646
Parecoxib in Renal Colic
A Multicenter Single-Blind, Single Dose Efficacy and Safety Pilot Study Comparing Intramuscular Parecoxib and Diclofenac in Renal Colic
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pain due to renal colic.
Detailed description
This study was prematurely discontinued May 3, 2004 due to slow recruitment. The decision to terminate the trial was not based on any safety concerns.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Parecoxib | |
| DRUG | Diclofenac |
Timeline
- Start date
- 2002-04-01
- Completion
- 2004-04-01
- First posted
- 2005-08-31
- Last updated
- 2008-05-06
Locations
5 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00139646. Inclusion in this directory is not an endorsement.